Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 38174117)

  • 1. Stage-specific treatment of colorectal cancer: A microRNA-nanocomposite approach.
    Fadaka AO; Akinsoji T; Klein A; Madiehe AM; Meyer M; Keyster M; Sikhwivhilu LM; Sibuyi NRS
    J Pharm Anal; 2023 Nov; 13(11):1235-1251. PubMed ID: 38174117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of microRNA in colorectal carcinoma (CRC): a narrative review.
    Sado AI; Batool W; Ahmed A; Zafar S; Patel SK; Mohan A; Zia U; Aminpoor H; Kumar V; Tejwaney U
    Ann Med Surg (Lond); 2024 Jan; 86(1):308-318. PubMed ID: 38222721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs as potential drug targets for therapeutic intervention in colorectal cancer.
    Jafri MA; Zaidi SK; Ansari SA; Al-Qahtani MH; Shay JW
    Expert Opin Ther Targets; 2015; 19(12):1705-23. PubMed ID: 26189482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting miRNA and using miRNA as potential therapeutic options to bypass resistance in pancreatic ductal adenocarcinoma.
    Vahabi M; Dehni B; Antomás I; Giovannetti E; Peters GJ
    Cancer Metastasis Rev; 2023 Sep; 42(3):725-740. PubMed ID: 37490255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of MicroRNAs in Inflammation-Associated Colorectal Cancer: A Mechanistic Approach.
    Muthusami S; Ramachandran I; Krishnamoorthy S; Sambandam Y; Ramalingam S; Queimado L; Chaudhuri G; Ramachandran IK
    Endocr Metab Immune Disord Drug Targets; 2021; 21(1):67-76. PubMed ID: 32940190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
    To KK; Tong CW; Wu M; Cho WC
    World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA in colorectal cancer: new perspectives for diagnosis, prognosis and treatment.
    Bonfrate L; Altomare DF; Di Lena M; Travaglio E; Rotelli MT; De Luca A; Portincasa P
    J Gastrointestin Liver Dis; 2013 Sep; 22(3):311-20. PubMed ID: 24078989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of microRNA deregulation in colorectal cancer development and the clinical uses as a diagnostic and prognostic biomarker and therapeutic agent.
    Ahadi A
    Noncoding RNA Res; 2020 Sep; 5(3):125-134. PubMed ID: 32954092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-delivery of 5-fluorouracil and miRNA-34a mimics by host-guest self-assembly nanocarriers for efficacious targeted therapy in colorectal cancer patient-derived tumor xenografts.
    Xu J; Zhang G; Luo X; Wang D; Zhou W; Zhang Y; Zhang W; Chen J; Meng Q; Chen E; Chen H; Song Z
    Theranostics; 2021; 11(5):2475-2489. PubMed ID: 33500737
    [No Abstract]   [Full Text] [Related]  

  • 10. Biomarkers for Stratification in Colorectal Cancer: MicroRNAs.
    Fadaka AO; Pretorius A; Klein A
    Cancer Control; 2019; 26(1):1073274819862784. PubMed ID: 31431043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triumph against cancer: invading colorectal cancer with nanotechnology.
    Vinchhi P; Patel MM
    Expert Opin Drug Deliv; 2021 Sep; 18(9):1169-1192. PubMed ID: 33567909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Review on the Role of Nanosensors in Detecting Cellular miRNA Expression in Colorectal Cancer.
    Girigoswami K; Girigoswami A
    Endocr Metab Immune Disord Drug Targets; 2021; 21(1):12-26. PubMed ID: 32410567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissecting miRNA signature in colorectal cancer progression and metastasis.
    Huang X; Zhu X; Yu Y; Zhu W; Jin L; Zhang X; Li S; Zou P; Xie C; Cui R
    Cancer Lett; 2021 Mar; 501():66-82. PubMed ID: 33385486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs as Therapeutic Targets and Colorectal Cancer Therapeutics.
    Yamamoto H; Mori M
    Adv Exp Med Biol; 2016; 937():239-47. PubMed ID: 27573904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs in colorectal cancer: from diagnosis to targeted therapy.
    Orang AV; Barzegari A
    Asian Pac J Cancer Prev; 2014; 15(17):6989-99. PubMed ID: 25227782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer.
    Arndt GM; Dossey L; Cullen LM; Lai A; Druker R; Eisbacher M; Zhang C; Tran N; Fan H; Retzlaff K; Bittner A; Raponi M
    BMC Cancer; 2009 Oct; 9():374. PubMed ID: 19843336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dietary components on miRNA and colorectal carcinogenesis.
    Fadaka AO; Ojo BA; Adewale OB; Esho T; Pretorius A
    Cancer Cell Int; 2018; 18():130. PubMed ID: 30202241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs that regulate PTEN as potential biomarkers in colorectal cancer: a systematic review.
    Liu J; Ke F; Chen T; Zhou Q; Weng L; Tan J; Shen W; Li L; Zhou J; Xu C; Cheng H; Zhou J
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):809-820. PubMed ID: 32146564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.
    Brunet Vega A; Pericay C; Moya I; Ferrer A; Dotor E; Pisa A; Casalots À; Serra-Aracil X; Oliva JC; Ruiz A; Saigí E
    Oncol Rep; 2013 Jul; 30(1):320-6. PubMed ID: 23673725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-411 inhibits malignant biological behaviours of colorectal cancer cells by directly targeting PIK3R3.
    Zhao J; Xu J; Zhang R
    Oncol Rep; 2018 Feb; 39(2):633-642. PubMed ID: 29207180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.